Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Filings indexed 540 across all filing types
Latest filing 2015-10-08 AGM Information
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
AGM Information 2015
AGM Information Classification · 99% confidence The document is titled 'MEDDELELSE NR. 125' and explicitly discusses the 'Forløb af ordinær generalforsamling' (Proceedings of the Annual General Meeting). It confirms that the annual report and board proposals were adopted, and new board members and auditors were elected. This content directly relates to the outcomes and proceedings of the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length is very short (857 chars), but since it details the *results* and *proceedings* of the meeting itself, rather than just announcing that a report is available, AGM-R is more specific than RPA or RNS.
2015-10-08 Danish
AGM Information 2015
AGM Information Classification · 99% confidence The document is explicitly titled "Indkaldelse til ordinær generalforsamling" (Notice of Annual General Meeting) and details the date, time, location, and agenda for the meeting. The agenda includes standard AGM items like approving the annual report, electing the board, and voting on management proposals (including share repurchase authorization). This directly corresponds to the definition of AGM Information (AGM-R). Although it is a notice, the content is the core material for the AGM itself, making AGM-R a more specific fit than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2015-09-16 English
AGM Information 2015
AGM Information Classification · 98% confidence The document text is very short (335 characters) and is titled 'MEDDELELSE NR. 124' (Announcement No. 124). The key phrase is 'Indkaldelse til ordinær generalforsamling' (Invitation to the Annual General Meeting) followed by 'Vedlagt offentliggøres selskabets indkaldelse...' (Attached is published the company's invitation...). This structure—a brief announcement stating that the AGM invitation material is attached or published—fits the definition of an announcement regarding a meeting, rather than the full AGM presentation itself. Since the document explicitly concerns the 'ordinær generalforsamling' (Annual General Meeting), the most appropriate code is AGM-R (AGM Information), as it is the announcement/material related to the AGM.
2015-09-16 Danish
Report Publication Announcement 2015
Report Publication Announcement Classification · 98% confidence The document is titled "Årsrapport 2014/15" (Annual Report 2014/15) and contains a detailed summary of the company's performance for the fiscal year, including revenue, EBITDA, net result, balance sheet figures, and key ratios spanning multiple years (2010/11 to 2014/15). It also includes management commentary and future outlook for 2015/16. This content strongly indicates a comprehensive annual financial report. However, the final sentence states: "Årsrapport 2014/15 er vedhæftet som bilag til denne meddelelse. Derudover kan årsrapporten downloades på ChemoMetecs hjemmeside." (The Annual Report 2014/15 is attached as an appendix to this announcement. Furthermore, the annual report can be downloaded on ChemoMetec's website.). This structure—a brief announcement summarizing the results and explicitly stating the full report is attached/available—fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' rule). Although the text contains the substance of an Annual Report, the document itself functions as the announcement of its release. Given the explicit reference to the full report being attached/downloadable, RPA is the most accurate classification for this specific filing document.
2015-09-16 English
Earnings Release 2015
Earnings Release Classification · 100% confidence The document is titled 'MEDDELELSE NR. 123' and dated September 16, 2015. It contains a summary of significant financial performance ('Betydelig fremgang i omsætning og indtjening') for the fiscal year 2014/15, including revenue (DKK 61.2 mio.) and EBITDA (DKK 11.4 mio.). Crucially, the final paragraph states: 'Årsrapport 2014/15 er vedhæftet som bilag til denne meddelelse. Derudover kan årsrapporten downloades på ChemoMetecs hjemmeside...' (The Annual Report 2014/15 is attached as an appendix to this announcement. Furthermore, the annual report can be downloaded from ChemoMetec's website...). Since the document itself is a short announcement summarizing the results and explicitly stating that the full 'Årsrapport' (Annual Report) is attached or available elsewhere, it fits the definition of a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) or Interim Report (IR). The document length (3447 chars) also supports this conclusion based on the 'MENU VS MEAL' rule. FY 2015
2015-09-16 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a short announcement (MEDDELELSE NR. 122, 1115 chars) from ChemoMetec A/S, dated July 1, 2015. The content explicitly states that the company has purchased a domicile property ('Køb af selskabs domicil') as required by securities trading law (§ 27). This action relates to securing space for future growth, which is a form of capital expenditure or asset acquisition, but more specifically, it is a significant corporate transaction affecting the company's structure/assets. It is not a standard earnings release, management change, or dividend notice. Since it involves a significant transaction (property purchase) that is being officially disclosed, it fits best under Capital/Financing Update (CAP) as it relates to securing assets for future growth, or potentially Regulatory Filings (RNS) if no other category fits perfectly. Given the nature of securing physical assets for expansion, CAP is a strong candidate, although it is not a typical financing event like issuing debt or equity. However, looking at the definitions, it is a material corporate event disclosure. Since it is a specific announcement about a major asset acquisition related to operational capacity, and it is not explicitly covered by other transaction types (like M&A or Share Issue), it is a material corporate event. If we strictly adhere to the definitions, 'CAP' covers 'capital structure changes' or 'fundraising'. This is an asset acquisition. 'RNS' is the fallback. Given the short nature and the specific disclosure requirement ('I henhold til værdipapirhandelslovens § 27'), it is a mandatory regulatory disclosure. Since it doesn't fit perfectly into the transactional categories (like M&A or Share Issue), RNS (Regulatory Filings / miscellaneous) is the most appropriate fallback for a specific, non-standard material disclosure.
2015-07-01 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.